Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

BACKGROUND: Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis. AIM: The aim of this study was to comprehensively assess th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dig Dis Sci
Main Authors: Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621699/
https://ncbi.nlm.nih.gov/pubmed/26386854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3868-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados